The influence of BIBW22BS, a dipyridamole derivative, on the antiproliferative effects of 5-fluorouracil, methotrexate and gemcitabine in vitro and in human tumour xenografts

European Journal of Cancer

Volumn 31, Issue 13-14, 1995, Pages 2313-2319

  Jansen, W J M ^a   Pinedo, H M ^a   van der Wilt, C L ^a   Feller, N ^a   Bamberger, U ^b   Boven, E ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

5 fluorouracil; BIBW22BS; dipyridamole; gemcitabine; methotrexate; modulation; nucleoside transport

Indexed keywords

BIBW22BS; DIPYRIDAMOLE; DIPYRIDAMOLE DERIVATIVE; DOXORUBICIN; FLUOROURACIL; GEMCITABINE; METHOTREXATE; UNCLASSIFIED DRUG; VINCRISTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLON CANCER; CONTROLLED STUDY; DRUG INTERACTION; DRUG POTENTIATION; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL LINE; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL DIVISION; DEOXYCYTIDINE; DIPYRIDAMOLE; DOXORUBICIN; DRUG RESISTANCE; FEMALE; FLOXURIDINE; FLUOROURACIL; HUMANS; METHOTREXATE; MICE; MICE, NUDE; MORPHOLINES; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; PROTEIN BINDING; TRANSPLANTATION, HETEROLOGOUS; TRIAMTERENE; TUMOR CELLS, CULTURED; VINCRISTINE;

EID: 0029557153     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(95)00440-8     Document Type: Article

References (23)

1. Biochemical modulation of fluorouracil by dipyridamole: preclinical and clinical experience
2. Methotrexate and dipyridamole combination chemotherapy based upon inhibition of nucleoside salvage in humans
3. Phase I trial of 5-fluorouracil and dipyridamole administered by seventy-two-hour concurrent continuous infusion
4. BIBW 22, a dipyridamole analogue, acts as a bifunctional modulator on tumor cells by influencing both P-glycoprotein and nucleoside transport
5. Biochemical modulation of ‘classical’ multidrug resistance by BIBW22BS, a potent derivative of dipyridamole
6. Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multi-drug-resistance
7. Production of monoclonal antibodies to squamous cell carcinoma antigens
8. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays
9. Mechanisms of innate resistance to thymidylate synthase inhibition after 5-fluorouacil
10. Evaluation of thymidylate synthase following 5-fluorouracil treatment is prevented by the addition of leucovorin in murine colon tumors
11. Conventional agents in human ovarian cancer xenografts
12. The influence of the schedule and the dose of gemcitabine on the antitumour efficacy in experimental human cancer
13. Alteration of fluorouracil metabolism in human colon cancer cells by dipyridamole with a selective increase in fluorodeoxyuridine monophosphate levels
14. Interaction of deoxyuridine with fluorouracil and dipyridamole in a human colon cancer cell line
15. 5-Fluoropyrimidine induced DNA damage in human colon adenocarcinoma and its augmentation by the nucleoside transport inhibitor dipyridamole
16. The mechanism of action of methotrexate in cultured L5178Y leukemia cells
17. Augmentation of methotrexate cytotoxicity in human colon cancer cells achieved through inhibition of thymidine salvage by dipyridamole
18. Evaluation of the antitumor activity of gemcitabine (2′,2′-difluoro-2′deoxycytidine)
19. 1-acid glycoprotein
20. 1acid glycoprotein
21. Modulation of drug sensitivity by dipyridamole in multidrug resistant tumor cells in vitro
22. Dipyridamole modulates multidrug resistance and intracellular as well as nuclear levels of doxorubicin in B16 melanoma cells